Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hill Avenue Cannabis was a cannabis-focused operating subsidiary and brand platform of Hill Street Beverage Company, later Hill Incorporated, centered on cannabis-infused beverages, edibles, tablets, capsules, topicals, and ingredient technologies. The business was launched to commercialize adult-use cannabis consumer products under the Hill Avenue Cannabis banner, including the (V)ia beverage line, while also supporting business-to-business ingredient and licensing opportunities. Hill Avenue Cannabis was also described as comprising Hill Avenue Cannabis Brands and Hill Avenue Cannabis Technologies, with the latter built around DehydraTECH-enabled formulation and ingredient solutions. Available public information indicates it functioned primarily as a branded cannabis products and technology commercialization unit rather than a standalone drug-development biotech company. Current evidence suggests the brand/subsidiary is not independently active today and has effectively been folded into or superseded by the parent company's broader corporate structure.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hill Avenue Cannabis.